Binder Biomedical
Miami
About Binder Biomedical
Binder Biomedical, Inc. develops and supplies medical devices for the treatment of complex orthopedic and neurological spinal disorders. Its product portfolio focuses on applications for spine fusion surgery, including biologics. The company offers NEWTON Intervertebral Body Fusion System, a line of lumbar interbody spacers that include lumbar intervertebral body, anterior lumbar interbody, posterior lumbar intervertebral body, and transforaminal lumbar intervertebral body fusion devices. It also provides X-GRAFT, an interspinous allograft/donated human tissue; and cervical spacer, anterior lumbar spacer, and posterior lumbar spacer allografts designed to treat degenerative conditions of the spine. In addition, the company offers specialized implants that enable the maximization of disc height restoration and sufficient structural support while conforming to the anatomical requirements of the patient. It serves surgeons through sales agents and representatives in the United States and internationally. The company was founded in 2009 and is based in Boca Raton, Florida with an operations office in Miami, Florida.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $685.0K
- Funding stage: Seed
- Last round: Seed (Apr 2012)
- Website: binderspine.com
- Phone: +1.561.981.2682
Industries & Categories
Biopharma, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/binder-biomedical-1995422 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.